首页> 外国专利> Glucopyranosyloxypyrazole derivative, pharmaceutical composition containing the same, pharmaceutical use thereof and production intermediate thereof

Glucopyranosyloxypyrazole derivative, pharmaceutical composition containing the same, pharmaceutical use thereof and production intermediate thereof

机译:氨基葡萄糖基氧基吡唑衍生物,含有该衍生物的药物组合物,其药物用途及其生产中间体

摘要

The present invention provides glucopyranosyloxypyrazole derivatives represented by the general formula: CHEM wherein R1 is a hydrogen atom or a hydroxyalkyl group; one of Q and T is a group represented by the general formula; CHEM the other is an optionally substituted alkyl group or a cycloalkyl group; and R2 is a halogen atom, a hydroxy group, an optionally substituted alkyl group, an optionally substituted alkoxy group, an alkylthio group, a group of the general formula: -A-R3 wherein A is a single bond, an oxygen atom, a methylene group, an ethylene group, -OCH2- or -CH2O-; and R3 is a cycloalkyl group, a heterocycloalkyl group, an optionally substituted aryl group, an optionally substituted tiazolyl group or an optionally substituted pyridyl group, pharmaceutically acceptable salts thereof or prodrugs thereof, which exert an excellent inhibitory activity in human SGLT1, and therefore are useful as drugs for the prevention or treatment of a disease associated with hyperglycemia such as diabetes, diabetic complications or obesity, pharmaceutical compositions comprising the same, pharmaceutical uses thereof and production intermediates thereof.
机译:本发明提供了由通式:表示的吡喃葡萄糖基氧基吡唑衍生物,其中R 1为氢原子或羟烷基; Q和T之一是由通式表示的基团; <CHEM>另一个为任选取代的烷基或环烷基。 R 2为卤素原子,羟基,任选取代的烷基,任选取代的烷氧基,烷硫基,通式-AR 3的基团,其中A为单键,氧原子,亚甲基,亚乙基,-OCH 2-或-CH 2 O-; R 3为对人SGLT1具有优异抑制活性的环烷基,杂环烷基,任选取代的芳基,任选取代的噻唑基或任选取代的吡啶基,其药学上可接受的盐或其前药,因此,其可用作预防或治疗与高血糖症有关的疾病的药物,例如糖尿病,糖尿病并发症或肥胖症,包含其的药物组合物,其药物用途及其生产中间体。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号